Kolexia
Pigneur Benedicte
Pédiatrie
Hôpital Necker Enfants Malades
Paris, France
97 Activités
341 Followers

Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Maladie de Crohn Maladies inflammatoires intestinales Rectocolite hémorragique Colite Insuffisance intestinale Syndrome de l'intestin court Dysbiose Maladies intestinales Vascularite

Industries

Abbvie
27 collaboration(s)
Dernière en 2023
Biocodex
7 collaboration(s)
Dernière en 2023
Amgen
4 collaboration(s)
Dernière en 2023
Nestlé
2 collaboration(s)
Dernière en 2022

Dernières activités

ABRICO: Is Clostridioides Difficile Infection Associated With Changes in Bile Acid Profiles in Children With Ulcerative Colitis
Essai Clinique (Assistance publique – Hôpitaux de Paris)   18 janvier 2024
Efficacy of infliximab after loss of response of/intolerance to adalimumab in pediatric Crohn's disease: A retrospective multicenter cohort study of the "GETAID pédiatrique".
Journal of pediatric gastroenterology and nutrition   07 janvier 2024
Determinants of parenteral nutrition (PN) weaning in a pediatric cohort of short bowel syndrome (SBS) patients in the era of GLP-2 analogue treatment
Clinical nutrition ESPEN   01 décembre 2023
Session spéciale Q&R du "Printemps du Microbiote Intestinal" édition 2023.
Youtube @ FHU PaCeMM   10 juin 2023
Long-term treatment with teduglutide: a 48-week open-label single-center clinical trial in children with short bowel syndrome.
The American journal of clinical nutrition   03 mai 2023
Probiotiques chez l’enfant. Dr Bénédicte PIGNEUR, MCU-PH à l'Hôpital Necker Enfants - Malades, Paris
Youtube @ FHU PaCeMM   18 avril 2023
Ustekinumab Use in Pediatric Inflammatory Bowel Disease: A French Multicenter Study From the Pediatric GETAID.
Journal of pediatric gastroenterology and nutrition   08 mars 2023
P291 Long term outcomes of children with ulcerative colitis after acute severe colitis: a multicenter study from the GETAID pédiatrique group
Abstracts of the 18th Congress of ECCO Copenhagen, Denmark, March 1-4, 2023   30 janvier 2023
A critical review of adalimumab for the treatment of moderate-to-severe active ulcerative colitis in children.
Expert review of gastroenterology & hepatology   21 novembre 2022
Adalimumab Therapy in Pediatric Crohn Disease: A 2-Year Follow-Up Comparing "Top-Down" and "Step-Up" Strategies.
Journal of pediatric gastroenterology and nutrition   28 octobre 2022